Skip to main content
logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.8700
-0.0300 (-3.33%)
At close: Sep 1, 2026, 4:00 PM EDT
0.8500
-0.0200 (-2.30%)
After-hours: Sep 1, 2026, 7:56 PM EDT

RedHill Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5582913135
Market Cap Growth
211.20%-34.04%-72.32%124.48%-90.53%-55.27%
Enterprise Value
23124118188
Last Close Price
0.901.036.2136.50140.302580.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---1.20--
PS Ratio
17.9618.34--0.211.58
PB Ratio
1.071.23-1.7013.88-0.2615.23

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.829.07--1.922.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.250.25-0.080.57-2.539.89
Net Debt / Equity Ratio
-0.68-0.680.91-2.12-2.125.61
Net Debt / EBITDA Ratio
0.370.370.670.58-2.96-0.79
Net Debt / FCF Ratio
0.400.400.480.26-3.49-0.76
Asset Turnover
0.010.01--0.360.48
Inventory Turnover
----2.584.63
Quick Ratio
0.300.300.340.440.280.87
Current Ratio
0.340.340.540.810.441.09
Return on Equity (ROE)
------859.70%
Return on Assets (ROA)
-22.79%-22.79%-19.70%-6.56%-15.75%-28.06%
Return on Capital Employed (ROCE)
-129.10%-129.10%154.90%-311.60%111.00%-81.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.35%-8.18%-103.97%83.26%-560.09%-72.30%
FCF Yield
-140.09%-137.19%-112.47%-58.60%-229.63%-48.20%
Buyback Yield / Dilution
-213.49%-156.37%-375.56%-320.45%-32.46%-27.72%
SEC Filings: 10-K · 10-Q